advertisement
14 Costing studies; pharmacoeconomics (5)
Showing records 1 to 5
Display all abstracts in classification 14 Costing studies; pharmacoeconomics
Search within classification 14 Costing studies; pharmacoeconomics22759 Population-Based Studies in Ophthalmology
Wong TY; Hyman L
American Journal of Ophthalmology 2008; 146: 656-663
22502 Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model
Stewart WC; Stewart JA; Mychaskiw MA
Eye 2009; 23: 132-140
22849 Economic evaluation of medication, laser trabeculoplasty and filtering surgeries in treating patients with glaucoma in the US
Cantor LB; Katz LJ; Cheng JW; Chen E; Tong KB; Peabody JW
Current Medical Research and Opinion 2008; 24: 2905-2918
22919 The impact of co-payment increases on dispensings of government-subsidised medicines in Australia
Hynd A; Roughead EE; Preen DB; Glover J; Bulsara M; Semmens J
Pharmacoepidemiology and Drug Safety 2008; 17: 1091-1099
22944 Cost effectiveness of travoprost versus a fixed combination of latanoprost/timolol in patients with ocular hypertension or glaucoma: Analysis based on the UK general practitioner research database
De Natale R; Lafuma A; Berdeaux G
Clinical Drug Investigation 2009; 29: 111-120
